Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

3 Mega-Cap Healthcare Stocks to Buy for the Rest of the Year

Published 11/23/2021, 11:40 AM
Updated 11/23/2021, 12:31 PM
© Reuters.  3 Mega-Cap Healthcare Stocks to Buy for the Rest of the Year

© Reuters. 3 Mega-Cap Healthcare Stocks to Buy for the Rest of the Year

Healthcare has long been considered a defensive sector that provides consistent returns to investors. And with the continuing advancements in medicines and increasing demand for healthcare services, we expect fundamentally sound mega-cap healthcare stocks Pfizer (PFE), Novo Nordisk (NYSE:NVO), and AbbVie (ABBV) to generate stellar returns this year and beyond. So, let’s examine these names.The healthcare industry has long enjoyed investors’ attention because of its defensive and stable nature. But the COVID-19 pandemic has thrust the industry into the limelight. And investors’ interest in healthcare stocks is evident in the Health Care Select Sector SPDR’s (XLV) 22% returns over the past year.

The increasing use of technology in modern healthcare is expected to bolster the industry. Technological advances in telemedicine, digital health platforms, wearable devices, and genome sequencing, as examples, are expected to bring the cost of quality healthcare down. According to a Global Market Insights Inc. report, the healthcare artificial intelligence (AI) market is expected to reach $34.5 billion by 2027.

The aging population and advancements in the treatment of chronic diseases are also expected to spur the growth of the healthcare industry. So, considering all this, we think it could be wise to invest in mega-cap quality healthcare stocks Pfizer Inc. (NYSE:PFE), Novo Nordisk A/S (NVO), and AbbVie Inc . (NYSE:ABBV) for the rest of the year.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.